We used the ADVIA 2120 Hematology System (Bayer HealthCare, Diagnostics Division, Tarrytown, NY) The cardioprotective effects of regular aerobic physical exercise are well known and reflected in official recommendations stressing the importance of physical activity. The American Heart Association, the American College of Sports Medicine, the Centers for Disease Control and Prevention, and the Surgeon General have issued guidelines advising physical exercise to reduce the risk of heart attack. 1,2 However, heavy physical exertion can trigger the onset of acute myocardial infarction; strenuous exercise, therefore, has been called a "two-edged sword, both triggering and preventing myocardial infarction." 3 Most myocardial infarctions can be attributed to the occlusion of coronary arteries by platelet-rich thrombi. 4 A number of studies have investigated the effects of vigorous exercise on the coagulation system. Most of these studies found evidence of activation of the coagulation and fibrinolytic cascade. 2, [5] [6] [7] [8] [9] In the majority of studies, platelet counts were elevated and there was evidence of platelet activation following prolonged exertion. [10] [11] [12] [13] [14] [15] Many of the investigations focusing on platelets measured in vitro platelet aggregation or soluble factors correlated with platelet activation; such studies are labor-intensive and require highly trained personnel and specialized equipment, limiting their availability in many settings, and provide only indirect evidence of in vivo platelet activation.
A b s t r a c t

We used the ADVIA 2120 Hematology System (Bayer HealthCare, Diagnostics Division, Tarrytown, NY) to study the effects of vigorous exercise on CBC count, WBC differential, RBC fragmentation, and platelet activation parameters in 32 healthy participants in a 26.2-mile (42.2-km) marathon. The runners demonstrated increases in hematocrit and platelet count consistent with dehydration and leukocytosis indicative of demargination of neutrophils or inflammation secondary to tissue destruction (eg, rhabdomyolysis). The number of RBC fragments was increased after the race (P = .008), consistent with exercise-induced hemolysis. The mean platelet component, a measure of platelet granularity, was decreased (P < .0001), and the number of platelet clumps was increased (P = .0026), providing evidence for in vivo platelet activation during the marathon. By using direct measurement of platelet granularity, our study confirms the in vivo activation of platelets by vigorous exercise and establishes the usefulness of automated cell counters for the assessment of platelet activation and of RBC fragmentation in this setting.
The cardioprotective effects of regular aerobic physical exercise are well known and reflected in official recommendations stressing the importance of physical activity. The American Heart Association, the American College of Sports Medicine, the Centers for Disease Control and Prevention, and the Surgeon General have issued guidelines advising physical exercise to reduce the risk of heart attack. 1, 2 However, heavy physical exertion can trigger the onset of acute myocardial infarction; strenuous exercise, therefore, has been called a "two-edged sword, both triggering and preventing myocardial infarction." 3 Most myocardial infarctions can be attributed to the occlusion of coronary arteries by platelet-rich thrombi. 4 A number of studies have investigated the effects of vigorous exercise on the coagulation system. Most of these studies found evidence of activation of the coagulation and fibrinolytic cascade. 2, [5] [6] [7] [8] [9] In the majority of studies, platelet counts were elevated and there was evidence of platelet activation following prolonged exertion. [10] [11] [12] [13] [14] [15] Many of the investigations focusing on platelets measured in vitro platelet aggregation or soluble factors correlated with platelet activation; such studies are labor-intensive and require highly trained personnel and specialized equipment, limiting their availability in many settings, and provide only indirect evidence of in vivo platelet activation.
Automated cell counters, originally designed to provide CBC counts, WBC differentials, and reticulocyte counts, increasingly are able to provide additional novel parameters. For example, the ADVIA 120 Hematology System and its successor model the ADVIA 2120 (both Bayer HealthCare, Diagnostics Division, Tarrytown, NY) measure volume and refractive index of individual platelets simultaneously by using 2 angles of light scatter. 16 The platelet refractive index is a measure of platelet density. Parameters available on this system include the platelet volume distribution width (PDW), which is a measure of platelet size variation, mean platelet component concentration (MPC), a measure of platelet granulation, the platelet component distribution width (PCDW), a measure of the variation in platelet shape, mean platelet mass (MPM), platelet mass distribution width, and the number of platelet clumps and of RBC fragments. 17 Several reports have shown that reductions in the MPC (reflecting a decrease in platelet granularity) are associated with an increase in CD62 expression and are indicative of platelet activation. [17] [18] [19] [20] The MPC has been used to study the role of platelet activation in coronary disease and in diabetic retinopathy and for monitoring the efficacy of antiplatelet therapies. [20] [21] [22] The purpose of the present study was to determine whether strenuous exercise led to in vivo platelet activation, as reflected by platelet degranulation. Therefore, we analyzed whole blood samples from 32 participants in a marathon race with an ADVIA 2120 Hematology System.
Materials and Methods
Specimens
All participants gave written informed consent. The study was approved by the institutional review board of the Massachusetts General Hospital, Boston. Participants were 32 runners (mean ± SD age, 49 ± 7 years; 27 male, 5 female) registered to run the 109th Boston Athletic Association Marathon in 2005. Medical and running histories obtained by questionnaire indicated no known coronary heart disease and a mean ± SD of 36 ± 14 training miles per week. Blood samples were obtained approximately 36 hours before and immediately (< 30 minutes) after the race from an antecubital vein using a 21-gauge butterfly needle into Vacutainer K 2 EDTA Plus plastic tubes (BD Medical Systems, Franklin Lakes, NJ). All samples were analyzed within 90 minutes of venipuncture.
Sample Analysis
CBC counts, WBC differentials, and reticulocyte counts were performed on whole blood samples anticoagulated with EDTA with an ADVIA 2120 Hematology System. This analyzer uses a cyanide-free method for the measurement of hemoglobin, isovolumetric sphering and light scatter for all other RBC and platelet parameters, and peroxidase staining and light scatter for the WBC measurements. 16 Reticulocyte counts are based on the uptake of a nucleic acid dye, oxazine 750, by RNA. The CBC parameters included WBC counts, hematocrit, hemoglobin, RBC count, platelet count, mean corpuscular volume (MCV), mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and red cell distribution width (RDW). The WBC differential consisted of the percentages of neutrophils, lymphocytes, monocytes, eosinophils, basophils, and large unstained cells. In addition to the platelet count, the following platelet parameters were determined: mean platelet volume, PDW, MPC, PCDW, MPM, platelet clumps, and number of large platelets (>20 fL). The number of RBC fragments (<30 fL) also was enumerated.
Statistical Analysis
A 2-tailed paired t test was used to evaluate differences between prerun samples and samples obtained immediately after the marathon. Statistical analysis was performed using Microsoft Excel software (Microsoft, Redmond, WA).
Results
The 2005 Boston marathon was run on a sunny day, at a temperature of 70°F (21.1°C) with a light northwesterly wind of 3 mph. Over 20,000 runners participated in the annual event. Whole blood samples were obtained from 32 runners 36 hours before the race and immediately after completion of the 26.2-mile (42.2-km) course. The CBC, WBC differential, reticulocyte count, and platelet activation values are shown in ❚Table 1❚, ❚Table 2❚, and ❚Table 3❚. Comparison of CBC values showed a significant increase in WBC count, hematocrit, hemoglobin, and RBC count. The changes in MCV, RDW, mean corpuscular hemoglobin concentration, and reticulocyte counts, while statistically significant (P < .05), were unlikely to be of clinical significance. There were no statistically or clinically significant changes in platelet count and mean corpuscular hemoglobin (Table 1) .
The increase in the WBC count was mainly due to an increase in the absolute number of neutrophils. Absolute counts for all WBC types except neutrophils were clinically unchanged after the race (Table 2) .
There was no significant change in mean platelet volume, PDW, and number of large platelets after the marathon. The MPC, PCDW, and MPM were statistically significantly lower after the race than before the event; the numbers of RBC fragments and platelet clumps were statistically significantly increased after the race (Table 3) .
Discussion
We report the effects of participation in a marathon race on all basic hematologic parameters routinely reported by a clinical hematology laboratory and on markers of platelet activation and RBC fragmentation. Our findings confirm earlier reports, including a previous study by our group, that have shown increases in WBC count after a marathon. [23] [24] [25] [26] This leukocytosis after a race is generally assumed to be due to demargination of WBCs induced by increased blood flow or by an inflammatory response caused by tissue injury, for example, rhabdomyolysis. The increases in RBC count, hemoglobin, and hematocrit are most likely due to dehydration caused by the race. In our previous study of 37 participants of the 2001 Boston Marathon, we observed a drop in hematocrit (from 44.0% [0.44] to 43.0% [0.43]; P = .01, 2-tailed t test), 26 as opposed to the increase seen in the present study. This difference could be due to a change in fluid replacement guidelines: In 2003 the International Marathon Medical Directors Association and USA Track and Field issued recommendations advising runners to drink ad libitum between 400 and 800 mL/h, as opposed to the previous "as much as possible" recommendations. 27, 28 Alternatively, the difference between the findings in the 2 marathons may be due to differences in the timing of the phlebotomy after the race (<30 minutes in this study vs < 2 hours in the group examined in 2001, allowing more time for postrace fluid intake). Like the RBC changes, the (statistically nonsignificant) elevation of platelet counts also could be due to dehydration, or it could be part of the acute phase response to tissue injury; our group has described an increase in C-reactive protein after a marathon. 6 Exercise-induced hemolysis is especially associated with running and is thought to be due to mechanical trauma to RBCs during footstrike. 29 Our finding of an increased number of RBC fragments after the marathon is a reflection of this phenomenon ( Table 3 ) and shows that an automated cell counter can be used to quantify the degree of RBC destruction caused by long-distance running. The increase in RDW and the decrease in MCV after the race also may reflect RBC fragmentation.
Vigorous exercise is associated with a significant increase in the risk of acute myocardial infarction. 4 It is estimated that 6% to 17% of all sudden deaths are associated with exertion. 30 Platelet activation can have an important role in the acute coronary syndrome; several groups, therefore, have probed the activation status of platelets after physical exertion. These investigators generally have used in vitro platelet aggregation assays or measurements of soluble factors associated with platelet activation.
Among investigators using aggregation studies, a group studying participants in the Athens marathon found that although in vitro platelet aggregation induced by adenosine diphosphate (ADP) and by collagen increased in participants in a marathon run in extreme heat, it remained unaltered when the event took place in more moderate weather. 12, 13 Rock and colleagues 15 reported that 24 hours after participation in a marathon, platelet aggregation in response to epinephrine, ADP, and collagen was decreased, indicating activation during the period of exercise. Similarly, Knudsen and coworkers 14 reported decreases in ADP-induced platelet "aggregability" and decreased serotonin release induced by ADP and collagen after long-distance running, consistent with exhaustion of platelet aggregation capacity. Limitations of these investigations include the possibility that changes in platelet counts in some patients may have influenced the results of the in vitro platelet aggregation studies.
Some groups have used soluble plasma factors to study exercise-induced platelet activation, focusing mainly on β-thromboglobulin, platelet factor 4 (PF4), and glycoprotein Ib. 31 Schernthaner et al 32 found a 2-to 3-fold increase in β-thromboglobulin and PF4 levels after exercise. Placanica and colleagues 33 reported that patients with ischemic heart disease had high basal concentrations of PF4 and that these levels increased with exercise. In the study by Knudsen and coworkers, 14 PF4 levels were increased immediately following a long-distance run.
The ADVIA 2120 Hematology System determines platelet parameters with 2-angle light-scatter analysis. The 2 scattering signals obtained from each platelet are converted into a cell volume measure and a refractive index measure; the refractive index measure is used to calculate the MPC, a measure that indicates the amount of platelet granulation. 17, 19 A decrease in the MPC has been demonstrated to correlate with anticoagulant-induced and thrombin-stimulated platelet activation. 17, 18 A decrease in MPC also was shown to correlate with CD62 expression on the platelet membrane and electron microscopic changes associated with platelet activation. 17, 20 Kennon and colleagues 21 found that the MPC is lower in acute myocardial infarction than in unstable angina, confirming the central role of platelet activation in the pathogenesis of the acute coronary syndrome. Similarly, Bae and coworkers 22 found that the MPC was lower in patients with diabetic retinopathy, implying a role for platelet activation in the pathogenesis of this disease.
Our finding of a decrease in MPC after running a marathon indicates that platelet activation (degranulation) occurs in vivo during the race (Table 3 ). The decrease in mean MPC in our study (27. 3 to 26.0 g/dL; P < .0001) was similar in magnitude to the differences reported by Kennon and colleagues 21 (25.9 vs 24.7 g/dL; P = .0001) for unstable angina vs acute myocardial infarction but less than the difference reported by Bae and coworkers 22 for patients with diabetic retinopathy vs control subjects (22.5 vs 26.9 g/dL; P < .05). The increase in the number of platelet clumps also is indicative of platelet activation (Table 3) . Our results are consistent with the findings of earlier studies that showed evidence for platelet activation by vigorous exercise as measured by in vitro platelet aggregation studies and by the measurement of plasma factors released by activated platelets. In addition, our studies confirm the use of the MPC as a measure of platelet activation. The availability of the MPC on an automated platform in the routine hematology laboratory with no additional labor requirements is a clear advantage over other methods to measure platelet activation.
We used a modern cell counter to study the effects of a marathon on platelets and on RBC integrity and obtained evidence for in vivo platelet activation and for RBC fragmentation. Our findings indicate that further study is warranted to investigate the use of automated hematology systems to rapidly identify patients who may benefit from specific therapeutic interventions directed at counteracting platelet activation. 
